Llewelyn Linda bought HCAT
February 25, 2026 · Form 4 insider transaction
Llewelyn Linda bought 191,500 shares of Health Catalyst, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
191,500
Price
$0.00
Total value
N/A
InsiderLlewelyn Linda
RoleOfficer
CompanyHealth Catalyst, Inc. (HCAT)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 25, 2026
Filing dateFebruary 27, 2026
Shares owned after334,763
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will vest in 12 equal quarterly installments beginning on March 1st 2026.